Journal
ARTHRITIS AND RHEUMATISM
Volume 63, Issue 4, Pages 1021-1033Publisher
WILEY-BLACKWELL
DOI: 10.1002/art.30151
Keywords
-
Categories
Funding
- Japanese Ministry of Education
- International Research Center for Molecular Science in Tooth and Bone Diseases [18109011, 18659438, 18123456, 20013014]
- Japan Space Forum
- National Space Development Agency of Japan
- Japan Society for Promotion of Science
- Genome Science
- Mitsubishi Pharma Research Foundation
- Grants-in-Aid for Scientific Research [23659868, 23791628, 22114009] Funding Source: KAKEN
Ask authors/readers for more resources
Objective. Regeneration of bone requires the combination of appropriate drugs and an appropriate delivery system to control cell behavior. However, the delivery of multiple drugs to heal bone is complicated by the availability of carriers. The aim of this study was to explore a new system for delivery of a selective EP4 receptor agonist (EP4A) in combination with low-dose bone morphogenetic protein 2 (BMP-2). Methods. Combined delivery of EP4A and BMP-2 was carried out with a nanogel-based scaffold in the shape of a disc, to repair critical-size circle-shaped bone defects in calvariae that otherwise did not heal spontaneously. Results. Combination treatment with EP4A and low-dose BMP-2 in nanogel efficiently activated bone cells to regenerate calvarial bone by forming both outer and inner cortical plates as well as bone marrow tissue to regenerate a structure similar to that of intact calvaria. EP4A enhanced low-dose BMP-2-induced cell differentiation and activation of transcription events in osteoblasts. Conclusion. These data indicate that combined delivery of EP4A and low-dose BMP-2 via nanogel-based hydrogel provides a new system for bone repair.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available